COVID-19 infection-associated coagulopathy: Pathophysiology and clinical implications.
作者信息
Abutaleb Abdulrahman, Nathan Sandeep
机构信息
Department of Internal Medicine, University of Chicago, Chicago, IL, USA.
出版信息
Interv Neuroradiol. 2021 Oct;27(1_suppl):6-12. doi: 10.1177/15910199211035894.
Abstract
摘要
相似文献
1
COVID-19 infection-associated coagulopathy: Pathophysiology and clinical implications.新型冠状病毒肺炎感染相关凝血病：病理生理学及临床意义
Interv Neuroradiol. 2021 Oct;27(1_suppl):6-12. doi: 10.1177/15910199211035894.
2
Approach to the Patient with COVID-19-Associated Thrombosis: A Case-Based Review.COVID-19 相关血栓患者的处理方法：基于病例的综述。
Oncologist. 2020 Oct;25(10):e1500-e1508. doi: 10.1634/theoncologist.2020-0682. Epub 2020 Aug 31.
3
Pathomechanisms Underlying Hypoxemia in Two COVID-19-Associated Acute Respiratory Distress Syndrome Phenotypes: Insights From Thrombosis and Hemostasis.两种 COVID-19 相关急性呼吸窘迫综合征表型低氧血症的发病机制：血栓形成和止血的见解。
Shock. 2022 Jan 1;57(1):1-6. doi: 10.1097/SHK.0000000000001825.
4
COVID-19 Infection: Viral Macro- and Micro-Vascular Coagulopathy and Thromboembolism/Prophylactic and Therapeutic Management.COVID-19 感染：病毒巨微血管性凝血障碍和血栓栓塞/预防和治疗管理。
J Cardiovasc Pharmacol Ther. 2021 Jan;26(1):12-24. doi: 10.1177/1074248420958973. Epub 2020 Sep 14.
5
The coagulopathy, endotheliopathy, and vasculitis of COVID-19.COVID-19 的凝血功能障碍、血管内皮功能障碍和血管炎。
Inflamm Res. 2020 Dec;69(12):1181-1189. doi: 10.1007/s00011-020-01401-6. Epub 2020 Sep 12.
6
COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.COVID-19：凝血功能障碍、血栓形成风险和抗凝治疗的理由。
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620938149. doi: 10.1177/1076029620938149.
7
COVID-19-Associated Systemic Thromboembolism: A Case Report and Review of the Literature.COVID-19 相关的全身性血栓栓塞症：病例报告及文献复习。
Cardiorenal Med. 2020;10(6):462-469. doi: 10.1159/000511800. Epub 2020 Oct 22.
8
COVID-19 Coagulopathy: Current knowledge and guidelines on anticoagulation.新型冠状病毒肺炎相关凝血障碍：抗凝治疗的当前认识和指南。
Heart Lung. 2021 Mar-Apr;50(2):357-360. doi: 10.1016/j.hrtlng.2021.01.011. Epub 2021 Jan 20.
9
Incidence of Venous Thromboembolism in Critically Ill Coronavirus Disease 2019 Patients Receiving Prophylactic Anticoagulation.新冠肺炎危重症患者预防性抗凝治疗的静脉血栓栓塞症发生率。
Crit Care Med. 2020 Sep;48(9):e805-e808. doi: 10.1097/CCM.0000000000004472.
10
Complement activation and coagulopathy - an ominous duo in COVID19.补体激活与凝血障碍——COVID-19 中的凶险组合。
Expert Rev Hematol. 2021 Feb;14(2):155-173. doi: 10.1080/17474086.2021.1875813. Epub 2021 Jan 22.
引用本文的文献
1
Cardio-cerebrovascular complications in COVID-19 patients: A retrospective cohort study.新型冠状病毒肺炎患者的心脑血管并发症：一项回顾性队列研究。
Front Med (Lausanne). 2022 Dec 22;9:1045274. doi: 10.3389/fmed.2022.1045274. eCollection 2022.
本文引用的文献
1
Registry of Arterial and Venous Thromboembolic Complications in Patients With COVID-19.COVID-19 患者的动脉和静脉血栓栓塞并发症登记册。
J Am Coll Cardiol. 2020 Nov 3;76(18):2060-2072. doi: 10.1016/j.jacc.2020.08.070.
2
Filter clotting with continuous renal replacement therapy in COVID-19.COVID-19中连续性肾脏替代疗法的滤器凝血
J Thromb Thrombolysis. 2021 May;51(4):966-970. doi: 10.1007/s11239-020-02301-6. Epub 2020 Oct 7.
3
Increased Incidence of Acute Pulmonary Embolism in Emergency Department Patients During the COVID-19 Pandemic.COVID-19大流行期间急诊科患者急性肺栓塞发病率增加。
Acad Emerg Med. 2020 Dec;27(12):1340-1343. doi: 10.1111/acem.14148. Epub 2020 Nov 20.
4
Incidence of venous thromboembolism in coronavirus disease 2019: An experience from a single large academic center.2019 年冠状病毒病患者静脉血栓栓塞症的发生率：来自单一大型学术中心的经验。
J Vasc Surg Venous Lymphat Disord. 2021 May;9(3):585-591.e2. doi: 10.1016/j.jvsv.2020.09.006. Epub 2020 Oct 5.
5
Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.用于预测危重症 COVID-19 患者静脉血栓栓塞症的生物标志物。
Thromb Res. 2020 Dec;196:308-312. doi: 10.1016/j.thromres.2020.09.017. Epub 2020 Sep 15.
6
CT imaging of pulmonary embolism in patients with COVID-19 pneumonia: a retrospective analysis.COVID-19 肺炎患者肺栓塞的 CT 影像学表现：一项回顾性分析。
Eur Radiol. 2021 Apr;31(4):1915-1922. doi: 10.1007/s00330-020-07300-y. Epub 2020 Sep 22.
7
Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients.D-二聚体升高和未抗凝与重症 COVID-19 患者的 PE 相关。
Eur Respir J. 2020 Oct 22;56(4). doi: 10.1183/13993003.01811-2020. Print 2020 Oct.
8
Management and Outcomes of Patients With STEMI During the COVID-19 Pandemic in China.中国 COVID-19 大流行期间 STEMI 患者的管理和结局。
J Am Coll Cardiol. 2020 Sep 15;76(11):1318-1324. doi: 10.1016/j.jacc.2020.06.039. Epub 2020 Aug 19.
9
Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey.新型冠状病毒肺炎住院患者中急性呼吸窘迫综合征的发病率及预后：一项全球文献综述
Crit Care. 2020 Aug 21;24(1):516. doi: 10.1186/s13054-020-03240-7.
10
Assessment of Lupus Anticoagulant Positivity in Patients With Coronavirus Disease 2019 (COVID-19).2019年冠状病毒病（COVID-19）患者狼疮抗凝物阳性的评估
JAMA Netw Open. 2020 Aug 3;3(8):e2017539. doi: 10.1001/jamanetworkopen.2020.17539.
Zotero 插件